Consistently, during the current global pandemic, Open Science collaboration has contributed to the rapid translation of clinical and scientific knowledge into successful treatments. Despite this fact, many stakeholders still hesitate to construct policies and practices to support the adoption and implementation of Open Science. Therefore, concerns remain about inequities in the global information system and access to its benefits.
This episode was part of a podcast series funded by Pfizer to celebrate 2021 International Open Access Week. The series interviewed experts working within clinical and medical disciplines who shared their perspectives on the impact and benefit of open science for patients and key stakeholders.
Today's podcast guest is Dr Akhil Bansal who is a medical doctor and a former associate medical writer at Oxford PharmaGenesis. He is a policy and research analyst at Charity Entrepreneurship, a social VC that incubates and strategies for NGOs working in global health and health policy. Most work is in low-income countries, where access to scientific and health information is problematic and work is focused on incubating NGOs that seek to promote open development and access to science, especially in Sub-Saharan Africa.